Retrospective analysis of efficacy and safety of Gemcitabine-based chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX

BACKGROUND: Metastatic pancreatic adenocarcinoma (MPA) represents a highly lethal condition. Despite the improvements seen with FOLFIRINOX, there is no randomized data to guide treatment selection beyond this regimen. We aimed to evaluate the outcomes of patients with MPA progressing on FOLFIRINOX w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Gastrointest Oncol
Päätekijät: de Jesus, Victor Hugo Fonseca, Camandaroba, Marcos Pedro Guedes, Donadio, Mauro Daniel Spina, Cabral, Audrey, Muniz, Thiago Pimentel, de Moura Leite, Luciana, Sant’Ana, Lucas Ferreira
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2018
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6219982/
https://ncbi.nlm.nih.gov/pubmed/30505579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.06.08
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia